Thomas Eldered, founder and chairman of the board of Flerie AB (publ) (”Flerie”), has informed Flerie that he has decided to establish a foundation, Stiftelsen Eldered Foundation (the ”Foundation”). The purpose of the Foundation is to promote scientific research in medicine and related fields as well as culture and artistic activities. Thomas Eldered intends to transfer certain assets to the Foundation, including the holding of shares in Flerie that he indirectly owns through T&M Participation AB (”T&M Participation”). Following the transfer of the shares, the Foundation will indirectly own 23,408,380 shares in Flerie, corresponding to approximately 26.2 per cent of all shares and votes in Flerie.
”Life science and research have been my driving force throughout my professional life. With the Foundation, I want to ensure that part of the value I have built up over the years will continue to benefit medical research and culture over the longer term. My commitment to Flerie is as strong as ever”, says Thomas Eldered.
Thomas Eldered holds his shares in Flerie indirectly through the companies T&M Förvaltning AB (”T&M Förvaltning”) and T&M Participation. Prior to the transfer, T&M Participation held 28,894,461 shares in Flerie, corresponding to approximately 32.3 per cent of the shares and votes. As a first step, T&M Participation has carried out a reduction of its share capital through the redemption of certain of its shares held by T&M Förvaltning. The redemption consideration consisted of 5,486,081 shares in Flerie, which have thereby been transferred from T&M Participation to T&M Förvaltning.
Following the transfer, T&M Förvaltning holds 35,479,667 shares in Flerie, corresponding to approximately 39.7 per cent of the shares and votes, and T&M Participation holds 23,408,380 shares, corresponding to approximately 26.2 per cent. T&M Participation’s holding has thereby decreased from approximately 32.3 per cent to approximately 26.2 per cent and is now below the threshold of 30 per cent of the shares and votes in Flerie. Thomas Eldered’s total indirect holding in Flerie is not affected by this first step and remains unchanged at 58,888,047 shares, corresponding to approximately 65.9 per cent of the shares and votes. The transfer gives rise to a major shareholding notification regarding T&M Participation and to notifications of managers’ transactions regarding T&M Förvaltning and T&M Participation, as closely associated parties of Thomas Eldered. The notifications will be published separately.
The transfer of T&M Participation’s holding in Flerie to the Foundation is intended to be carried out in several steps and is expected to be completed during the first quarter of 2027. Upon completion of the process, Thomas Eldered will hold shares in Flerie indirectly only through T&M Förvaltning, corresponding to approximately 39.7 per cent of the shares and votes. The continued process is expected to give rise to further major shareholding notifications and notifications of managers’ transactions, which will be published as each step is completed.
The total number of shares and votes in Flerie is not affected by the transfers.
For more information, please contact:
Ted Fjällman, CEO of Flerie
E-mail: ir@flerie.com
Telephone: +46 (0)76 600 89 26
About Flerie
Flerie is an active long-term life science investor, with a broad and diversified portfolio of innovative companies based on pioneering science. We invest in product development and commercial growth opportunities globally alongside other leading investors, focusing predominantly on private companies that are otherwise difficult to access. Flerie’s active ownership model, broad network and resources support and accelerate the development of the portfolio projects, creating value for shareholders. Flerie AB’s ordinary share is listed on Nasdaq Stockholm with the ticker FLERIE. For further information please visit www.flerie.com.